Cargando…
Promotion of Bone Lesions Through the Myeloma Integrin α6-Mediated Osteolytic Signaling
Osteolytic destruction is a hallmark of multiple myeloma and impairs myeloma patients’ quality of life. However, the molecular mechanism underlying the pathogenesis of myeloma-associated bone disease remains unclear. In this study, we demonstrate the role of myeloma cell-expressed integrin α6 in bon...
Autores principales: | Liu, Huan, Wang, Zhiming, He, Jin, Li, Zongwei, Gao, Jerry Y., Liu, Rui, Lin, Pei, Yang, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209508/ https://www.ncbi.nlm.nih.gov/pubmed/34150666 http://dx.doi.org/10.3389/fonc.2021.692190 |
Ejemplares similares
-
Osteocyte CIITA aggravates osteolytic bone lesions in myeloma
por: Liu, Huan, et al.
Publicado: (2022) -
Osteosclerotic & osteolytic lesions in multiple myeloma
por: Ram, Rapur, et al.
Publicado: (2014) -
Sotatercept in patients with osteolytic lesions of multiple myeloma
por: Abdulkadyrov, Kudrat M, et al.
Publicado: (2014) -
Osteolytic lesions: Multiple myeloma or prostate cancer?
por: Devaraj, Akshitha, et al.
Publicado: (2023) -
Preventing osteolytic lesions and osteomyelitis in multiple myeloma
por: Dao, Aiken, et al.
Publicado: (2022)